|
|
|
Company
Name |
Short
Summary |
| Aegerion Pharmaceuticals |
Aegerion Pharmaceuticals is focused on the research and development of cholesterol-lowering drugs for the treatment of cardiovascular and metabolic disease. |
| Alpharma |
Alpharma
Inc. is a growing specialty pharmaceutical company
with global leadership positions in products for
humans and animals. |
| Axcan Pharma |
Axcan Pharma is focused on development and commercialization of products to treat gastrointestinal diseases. |
| BioVail |
Biovail
Corporation International is a full-service pharmaceutical
company that applies its proprietary drug delivery
technologies in developing "oral controlled-release"
products. |
| CorMedix |
CorMedix is focused on the research and development of products that have been previously tested in human clinical trials or marketed elsewhere for different indications for cardiorenal disease. |
| Enzon |
Enzon,
Inc. is a biopharmaceutical company developing
and commercializing enhanced therapeutics for
life-threatening diseases through the application
of its proprietary technologies, PEG-Modification
or PEG and Single-Chain Antibodies (SCAŽ). |
| King
Pharmaceuticals |
King
Pharmaceuticals manufactures a wide range of products
in several therapeutic areas. |
| NovaDel Pharma |
NovaDel Pharma is focused on the research and development of oral spray formulations of a broad range of marketed therapeutics. |
| Sanofi-Aventis |
Sanofi-Aventis is a large pharmaceutical company focused on the discovery, development, and commercialization of a wide range of drugs. |
| Valeritas |
Valeritas is focused on the development and commercialization of innovative drug delivery solution, with an initial focus on the treatment of diabetes. |
